Name | 2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide |
---|---|
Synonyms |
Benzamide, 2,6-difluoro-N-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-3-yl]-
2,6-Difluoro-N-{1-[2-fluoro-6-(trifluoromethyl)benzyl]-1H-pyrazol-3-yl}benzamide gsk-5498a |
Description | GSK-5498A is a selective small molecule blocker of CRAC channel(IC50=1 uM); inhibit mediator release from mast cells, and pro-inflammatory cytokine release from T-cells in a variety of species.IC50 value: 1 uM [1]Target: CARC channel blocker GSK-5498A completely inhibited calcium influx through CRAC channels. This led to inhibition of the release of mast cell mediators and T-cell cytokines from multiple human and rat preparations. Mast cells from guinea-pig and mouse preparations were not inhibited by GSK-5498A. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 403.3±45.0 °C at 760 mmHg |
Molecular Formula | C18H11F6N3O |
Molecular Weight | 399.290 |
Flash Point | 197.7±28.7 °C |
Exact Mass | 399.080627 |
PSA | 46.92000 |
LogP | 2.62 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.552 |
Storage condition | 2-8℃ |